Evidence map›Paper›PMID 24275038›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Mitotic phosphorylation of histone H3 threonine 80.

Sharra L Hammond, Stephanie D Byrum, Sarita Namjoshi, Hillary K Graves, Briana K Dennehey, Alan J Tackett, Jessica K Tyler

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. The 80Journal of microbiology and biotechnology · 2024
    Article
  3. Histone modification in podocyte injury of diabetic nephropathy.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Comprehensive Catalog of Currently Documented Histone Modifications.Cold Spring Harbor perspectives in biology · 2015
    Review
  17. High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2015
    Article
  18. Review
  19. Emerging clinical applications of selected biomarkers in melanoma.Clinical, cosmetic and investigational dermatology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sharra L HammondDepartment of Biochemistry and Molecular Biology; University of Texas; MD Anderson Cancer Center; Houston, TX USA; Department of Molecular and Cellular Biology; Baylor College of Medicine; Houston, Texas USA.
Stephanie D ByrumDepartment of Biochemistry and Molecular Biology; University of Arkansas for Medical Sciences; Little Rock, AR USA.
Sarita NamjoshiDepartment of Biochemistry and Molecular Biology; University of Texas; MD Anderson Cancer Center; Houston, TX USA.
Hillary K GravesDepartment of Biochemistry and Molecular Biology; University of Texas; MD Anderson Cancer Center; Houston, TX USA.
Briana K DenneheyDepartment of Biochemistry and Molecular Biology; University of Texas; MD Anderson Cancer Center; Houston, TX USA.
Alan J TackettDepartment of Biochemistry and Molecular Biology; University of Arkansas for Medical Sciences; Little Rock, AR USA.
Jessica K TylerDepartment of Biochemistry and Molecular Biology; University of Texas; MD Anderson Cancer Center; Houston, TX USA; Department of Molecular and Cellular Biology; Baylor College of Medicine; Houston, Texas USA.
Scripps MD Anderson Cancer Center · USUniversity of Arkansas for Medical Sciences · USBaylor College of Medicine · US

Funding

Chromatin Assembly, Structure and FunctionR01GM064475 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI TYLER, JESSICA K · 2002 to 2019
$4.4M
NIGMS NIH HHS GM64475NIGMS NIH HHS R01 GM064475
6 · The paper itself

Abstract

The onset and regulation of mitosis is dependent on phosphorylation of a wide array of proteins. Among the proteins that are phosphorylated during mitosis is histone H3, which is heavily phosphorylated on its N-terminal tail. In addition, large-scale mass spectrometry screens have revealed that histone H3 phosphorylation can occur at multiple sites within its globular domain, yet detailed analyses of the functions of these phosphorylations are lacking. Here, we explore one such histone H3 phosphorylation site, threonine 80 (H3T80), which is located on the nucleosome surface. Phosphorylated H3T80 (H3T80ph) is enriched in metazoan cells undergoing mitosis. Unlike H3S10 and H3S28, H3T80 is not phosphorylated by the Aurora B kinase. Further, mutations of T80 to either glutamic acid, a phosphomimetic, or to alanine, an unmodifiable residue, result in an increase in cells in prophase and an increase in anaphase/telophase bridges, respectively. SILAC-coupled mass spectrometry shows that phosphorylated H3T80 (H3T80ph) preferentially interacts with histones H2A and H4 relative to non-phosphorylated H3T80, and this result is supported by increased binding of H3T80ph to histone octamers in vitro. These findings support a model where H3T80ph, protruding from the nucleosome surface, promotes interactions between adjacent nucleosomes to promote chromatin compaction during mitosis in metazoan cells.

Indexed as

MitosisAmino Acid SequenceAntibodiesAntibody SpecificityCell Line, TumorChromatinHistonesHumansModels, MolecularMolecular Sequence DataMutationNucleosomesPhosphorylationProtein BindingThreonineAntibodiesChromatinHistonesNucleosomesThreoninechromatin condensationhistone phosphorylationmitosis

Identifiers

PMID24275038
PMCPMC3956540
OpenAlexW2091033200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.